Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ: CPIX · Real-Time Price · USD
3.110
-0.050 (-1.59%)
Mar 11, 2026, 3:10 PM EDT - Market open

CPIX Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
44.5237.8739.5542.0135.99
Revenue Growth (YoY)
17.57%-4.26%-5.85%16.75%-3.89%
Cost of Revenue
6.676.596.079.128.81
Gross Profit
37.8531.2833.4932.8927.17
Selling, General & Admin
31.0528.1529.126.8424.8
Depreciation & Amortization Expenses
4.034.758.15.074.37
Research & Development
5.574.825.836.695.68
Total Operating Expenses
40.6537.7143.0438.634.85
Operating Income
-2.79-6.43-9.55-5.7-7.68
Interest Income
0.460.330.290.10.03
Interest Expense
-0.5-0.61-0.67-0.59-0.1
Other Non-Operating Income (Expense)
-0.243.650.612.19
Total Non-Operating Income (Expense)
-0.03-0.033.270.122.12
Pretax Income
-2.81-6.47-6.28-5.58-5.56
Provision for Income Taxes
0.04-0.020.050.070.03
Net Income
-2.84-6.48-6.28-5.57-3.51
Minority Interest in Earnings
-0.030.04-0.05-0.08-0.1
Earnings From Discontinued Operations
----1.99
Net Income to Common
-2.84-6.48-6.28-5.57-3.51
Shares Outstanding (Basic)
1514141515
Shares Outstanding (Diluted)
1514141515
Shares Change (YoY)
5.65%-1.67%-1.82%-2.29%-1.70%
EPS (Basic)
-0.19-0.46-0.44-0.38-0.24
EPS (Diluted)
-0.19-0.46-0.44-0.38-0.24
Free Cash Flow
4.83-0.685.818.356.24
Free Cash Flow Growth
---30.40%33.86%18.29%
Free Cash Flow Per Share
0.33-0.050.410.570.42
Gross Margin
85.02%82.61%84.66%78.29%75.51%
Operating Margin
-6.27%-16.99%-24.16%-13.58%-21.34%
Profit Margin
-6.40%-17.02%-16.01%-13.45%-15.55%
FCF Margin
10.86%-1.79%14.70%19.88%17.34%
EBITDA
1.35-1.53-4.62-0.38-3.07
EBITDA Margin
3.04%-4.04%-11.68%-0.90%-8.53%
EBIT
-2.79-6.43-9.55-5.7-7.68
EBIT Margin
-6.27%-16.99%-24.16%-13.58%-21.34%
Effective Tax Rate
-1.43%0.35%-0.73%-1.23%-0.63%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q